Concordia Healthcare acquired Amdipharm Mercury Limited (AMCo) from Cinven for approximately $3.5B (~$1.2B cash + 8.49M shares + $1.4B assumed debt + up to $220M earn-out), gaining 190+ off-patent specialty products with reach in 100+ countries. Closed October 21, 2015. Concordia later collapsed under debt and rebranded as Advanz Pharma.
Did it work? Outcome assessment
Strategic verdict
Failed to Achieve
Financial impact
Impaired/Written Down
Pipeline outcome
Mixed
Assessment window: 5yr post-close.
Key facts
AnnouncedSep 08, 2015
ClosedOct 21, 2015
Deal value$3.5B
Deal typeAcquisition/Merger
Therapeutic areaMultiple specialty therapeutic areas